风险提示：基金有风险，投资需谨慎。 1月7日，A股市场震荡上行，科创板领涨，半导体设备、模拟芯片、半导体材料板块均上涨。截至13点 30分，半导体ETF南方(159325.SZ)涨1.13%，科创芯片ETF南方(588890.SH)涨1.60%，中微公司涨 4.94%。 国信证券观点显示，电子上游涨价趋势蔓延，存储、晶圆代工、PCB及LCD等环节供需紧张， 价格预期上涨。在存储领域，周期向上，云基础设施需求强劲，国产化窗口打开；晶圆代工方面， BCD工艺涨价，模拟芯片需求增加且国产替代加速。同时，国产光刻机验证推动晶圆厂（fab）扩产， 设备材料国产替代逻辑强化。AI算力需求持续拉动存储产业链增长，模拟芯片周期向上，GPU等核心 芯片领域迎来发展机遇。多家半导体企业加速产品迭代与商业化进程，形成从芯片到解决方案的完整产 品矩阵，行业技术创新与市场需求共振明显。此外，半导体探针卡行业具备高景气与国产替代双重驱动 逻辑。作为芯片封测核心耗材，探针卡2024年全球市场规模约186亿人民币，国内市场占比近15%，但 国产化率不足5%，替代空间显著。行业技术壁垒高，头部企业通过绑定IDM/代工厂获取技术迭代优 势，而国 ...

半导体ETF南方(159325.SZ)和科创芯片ETF南方(588890.SH)可覆盖上述芯片产业链中的优质企业，有助 于投资者系统把握AI驱动下的行业增长红利，建议重点关注。 风险提示：基金有风险，投资需谨慎。 资讯所属栏目还有更多独家策划、专家专栏，免费查阅>> 1月6日，A股市场普涨，沪深两市延续升势，科创板同步上扬。截至14点00分，半导体ETF南方 (159325.SZ)涨1.47%，科创芯片ETF南方(588890.SH)涨1.27%，中微公司涨4.45% 。 兴业证券认为，AI浪潮正推动算力需求爆发，带动服务器、AI芯片、光芯片、存储、PCB板等硬件环节 价值量显著提升。生成式AI的快速发展持续拉动消费支出增长，进一步加剧对底层算力基础设施的需 求，服务器与AI芯片成为核心受益领域。随着训练与推理成本逐步降低，AI应用生态有望迎来繁荣发 展，端侧AI展现出巨大潜力，智能耳机、智能眼镜等终端载体受到广泛关注。与此同时，存储芯片价 格已触底回升，行业复苏趋势明确，上游领域景气度持续改善。封测环节稼动率逐步回升，叠加AI芯 片对先进封装需求的强劲拉动，将迎来结构性增长机遇。在存储领域，全球DRAM市场 ...

12月30日，沪深两市窄幅震荡，石油石化、传媒板块涨幅居前。截至11点15分，科创芯片ETF南方 (588890.SH)涨0.99%，半导体ETF南方(159325.SZ)涨0.74%，睿创微纳涨4.71%。 板块受益于存储、模拟芯片、设备及AI芯片等多领域增长机遇，业绩空窗期后春季躁动行情值得期 待。科创芯片ETF南方(588890.SH)、半导体ETF南方(159325.SZ)聚焦产业中上游优秀硬质企业，汇集AI 竞跃的核心底座，同类指数中表现突出，具备中长期配置价值。 风险提示：基金有风险，投资需谨慎。 资讯所属栏目还有更多独家策划、专家专栏，免费查阅>> 政策层面，两会时间确定、"十五五"规划在即，工信部明确打造集成电路等新兴支柱产业，财政部强调 加大科技投入，国家创投引导基金启动聚焦硬科技，科技自立自强战略地位持续提升；产业层面，首部 大模型国家标准实施标志产业规范化新阶段，AI大模型迭代加速、端侧应用持续扩容，算力需求景气 度持续验证；博弈层面，美国加征301关税预期强化国产替代逻辑，国内半导体产业链从下游封测向上 游设备、材料、EDA持续突破。展望后市，短期关注两会政策预期演绎及年报预披露期业绩 ...

（原标题：AI需求推动全球半导体销售额持续增长，半导体设备ETF、半导体产业ETF上涨） 半导体板块上涨，半导体设备ETF、半导体产业ETF、半导体设备ETF易方达、半导体材料ETF、芯片 设备ETF、科创半导体ETF鹏华、半导体设备ETF基金、半导体设备ETF、科创半导体ETF、半导体ETF 南方、科创半导体设备ETF、芯片ETF上涨。 世界半导体贸易统计组织（WSTS）日前发布的最新预测显示，2025年全球半导体营收有望同比增长 22.5%至7720亿美元，2026年将再增长26.3%，达9750亿美元。这较6月预测2025年全球半导体市场规模 7009亿美元，同比增长11.2%；2026年增长8.5%，达7607亿美元的数据大幅提高。 机构认为，当前AI产业趋势持续，受益于国产算力建设的推进以及全球产业链格局的调整，国产先进 制程的发展空间正逐步打开。同时，存储涨价周期的幅度和持续时间均超预期。在先进制程及存储扩产 趋势下，2026年国产半导体设备订单有望加速增长，国产化率或进一步提升。 半导体设备ETF跟踪中证半导，标的指数中半导体设备+材料+集成电路设计三行业占比超90%，均为芯 片产业链中上游的" ...

Group 1 - The semiconductor sector experienced a significant rise at the beginning of trading, with companies such as Allwinner Technology and Hua Hong Semiconductor reaching new highs during the session [1] - Li Yang Chip and Demingli stocks hit the daily limit up, while Yutai Microelectronics saw an increase of over 10% [1] - Other companies including SourceJ Technology, Guoxin Technology, Jinghe Integration, Huafeng Measurement and Control, and Aojie Technology also saw gains [1] Group 2 - Related ETFs showed positive performance, with the leading chip ETF (159801) rising by 2.31% and a trading volume of 40.8161 million yuan [1] - The Southern Semiconductor ETF (159325) increased by 2.59%, with a trading volume of 4.9692 million yuan [1]

Group 1 - The article highlights the significant interest from public funds in the semiconductor and general equipment sectors, with 125 public funds conducting intensive research on 210 A-shares from May 12 to May 18, 2025 [2][3] - The semiconductor industry led the research frequency with 76 instances, indicating strong expectations for domestic semiconductor replacement processes [4][5] - The general equipment sector followed with 60 research instances, reflecting institutional intentions for comprehensive layout in high-end equipment manufacturing [4][5] Group 2 - The semiconductor industry is expected to break through cycles, with historical experiences suggesting that tariff impacts are temporary and do not hinder overall economic development [6][7] - The domestic semiconductor market has seen substantial growth, with sales of semiconductor equipment projected to rise from under $20 billion in 2010 to nearly $50 billion by 2024 [7][8] - The article notes that more domestic manufacturers are entering the high-end chip industry, marking a significant rise in China's technological capabilities [11] Group 3 - The article discusses the contrasting performance of Chinese and American tech stocks in 2025, with Chinese tech stocks showing gains of over 20% to 30% while American tech stocks averaged a decline of 5.9% [12][13] - The rise of Chinese tech stocks is attributed to technological leaps, domestic replacement, and valuation recovery, with companies like Chip Origin seeing significant stock price increases despite previous losses [15][16] Group 4 - The innovative drug sector is experiencing a revolutionary moment, with a growing market space driven by an aging population and increased health investments [33][34] - The Hang Seng Healthcare Index has risen by 31.89% since the beginning of the year, outperforming other indices [36] - The article highlights a record-breaking agreement between a domestic pharmaceutical company and Pfizer, marking a significant milestone for domestic innovative drugs [38][39] Group 5 - The innovative drug industry is transitioning from a "follower" to a "leader" position, with a notable increase in the number of innovative drug pipelines and global first-in-class drugs [46][49] - The article mentions that the innovative drug sector has received substantial policy support across various stages, contributing to its growth [50] - The performance of innovative drug-related ETFs has been strong, with many achieving returns above 30% this year [47][49]